Professor Hu Zhimin Use Of Hcc Treatment Of 34 Cases Of Primary Liver Cancer Experience

Objective: To evaluate the efficacy of the prescription of carcinoma of the liver in treating primary carcinoma of the liver.Methods: Collected 34 cases of patients who Suffering from primary carcinoma of the liver in September, 2002 to june, 2008 in the treatment of the prescription of carcinoma of the liver, 34 cases of this in accordance with its availability in patients with surgical resection, with or without radiotherapy and chemotherapy treatment line, as well as complications in the different basic dialectical be on the Treatment of carcinoma of the liver. After treatment in patients based on before and after treatment on tumor size change (according to CT examination), the quality of life changes, changes in clinical symptoms, survival time to analyze its short-term efficacy and long-term effect.Results: the 34 cases of patiens who Taking prescription of carcinoma of theliver , their symptoms had beeen improved evidently and the survival time also had been extended to some extent. the survival time that> 4 years in 2 cases,> 2 years in 4 cases, > 1 year in 16 cases, > 6 months in 8 cases , and < 6 months in 5 cases.Conclusion: Professor Hu Zhimin use prescription of carcinoma of the livertreat primary carcinoma of the liver at the same time alleviate the suffering of patients with effective control of the growth of cancer cells, and enhance the body immune function, improve the quality of life and prolongs the survival time of patients to palliative care The purpose of clinical application of a certain value, one of 21 cases of patients survive more than 1 year, accounting for 34 cases of patients with 50. 38%, 6 more patients to survive for more than 2 years, describes the value of Professor Hu Zhimin in the treatment using prescription of carcinoma of the liver in treating primary carcinoma of the liver...